Did The Market Read Molina Healthcare Stock Right?
For questions about this article or underlying research, email help@trefis.com.
Molina Healthcare (MOH) stock rose 71.9% from the February 6 close to November 4, 2026, against 11.8% for the S&P 500. The shares had fallen 26% in a single session on February 6 after Molina lost money in the fourth quarter of 2025. The company also forecast 2026 profit far below Wall Street expectations. The shares then slid to a low close of $122.65 on February 11 before the climb began. What has the company shown investors since that fall?
Molina’s Biggest One-Day Gain Followed A First-Quarter Profit Beat
Molina reported an adjusted profit for the first quarter of 2026 on April 22 that beat analysts’ estimates, helped by favorable medical costs. The stock rose 14.2% the next day, marking its largest one-session move since the February 6 fall. Most of the nine-month climb occurred by early May, since the shares returned 14.7% from May 6 to November 4.
The stock gained again in the month surrounding the October 22 third-quarter call, returning 16.0% from October 6 to November 4 while the S&P 500 lost 1.6%. Shares rose 8.9% on November 4 itself, the final day of that stretch. That day, stocks of big Medicaid operators jumped on the midterm election results, and Centene gained 12.6%. Before November 4, Molina was up 6.5% from October 6. Molina did not climb alone over the nine months, however: Centene stock rose 98% over the same dates.
Management Sees Early Signs Of 2027 Rates Matching Costs
On that October call, management said Molina’s overall rate increases for 2027 may approximate 6%. The company projects its medical cost trend, the yearly rise in what it pays for care, at 5.5% to 6% for 2027. Management said that range includes 50 basis points of conservatism.
Management also said it believes Molina is likely seeing the beginning of a turn in Medicaid margins. Medicaid makes up most of the company, bringing in 71.0% of Molina’s revenue in 2025. Management said each 100 basis points off the Medicaid medical cost ratio, the share of premiums paid out for care, is worth about $5 per share. The company’s 2027 outlook does not yet assume any such improvement.
Management did lower its preliminary 2027 premium revenue outlook to at least $45 billion, from $46.5 billion, because new Medicaid contracts in Georgia and Texas are delayed while state courts review the awards. Even so, the shares climbed while Molina’s reported margins thinned after the first quarter.
Molina Reported Thinner Margins After The First Quarter
Molina’s reported operating margin slipped from 1.6% in the first quarter of 2026 to 1.3% in the second. It then fell to 1.0% in the third quarter, placing it below the 1.2% reported in the third quarter of 2025.
Over the twelve months ending September 30, 2026, the operating margin was 0.6%, against 3.0% a year earlier. Only two of the 40 quarter-ends from the end of 2016 to September 2026 show a thinner twelve-month margin. Molina also lost $48 million over those twelve months, making its price-to-earnings ratio not meaningful.
The Medicaid medical cost ratio stood at 93% in the third quarter, and it is the number to watch when Molina reports in February 2027. Management plans to give its initial 2027 guidance in that report. So far, investors have bet on the 2027 outlook: the shares rose 71.9% even as the twelve-month operating margin fell to 0.6% from 3.0%.
Now You Know Molina Healthcare. Here Is A Better Way To Invest
Before you decide on MOH, consider owning 30 quality companies instead of one. The Trefis High Quality (HQ) Portfolio has returned 105% since its September 2020 launch, ahead of a benchmark that combines the S&P 500, S&P MidCap and Russell 2000.
Spot an error or want more like this? Tell us in 10 seconds.